answersLogoWhite

0

Modest progress has been made in the treatment of metastatic melanoma over the past decade. With the advent of high dose interleukin-2 (IL-2), it may be possible for a small number of patients to be cured of their disease

Despite this, the average median survival in patients treated for metastatic disease may be as short as nine months

User Avatar

Wiki User

15y ago

What else can I help you with?